Utah Medical Products (UTMD) Debt to Equity (2023 - 2025)
Historic Debt to Equity for Utah Medical Products (UTMD) over the last 8 years, with Q3 2025 value amounting to $0.0.
- Utah Medical Products' Debt to Equity changed N/A to $0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.0, marking a year-over-year change of. This contributed to the annual value of $0.0 for FY2024, which is 445.51% up from last year.
- Latest data reveals that Utah Medical Products reported Debt to Equity of $0.0 as of Q3 2025.
- Utah Medical Products' 5-year Debt to Equity high stood at $0.0 for Q4 2024, and its period low was $0.0 during Q3 2025.
- In the last 3 years, Utah Medical Products' Debt to Equity had a median value of $0.0 in 2023 and averaged $0.0.
- Within the past 5 years, the most significant YoY rise in Utah Medical Products' Debt to Equity was 445.51% (2024), while the steepest drop was 445.51% (2024).
- Utah Medical Products' Debt to Equity (Quarter) stood at $0.0 in 2023, then rose by 4.46% to $0.0 in 2024, then dropped by 15.14% to $0.0 in 2025.
- Its Debt to Equity was $0.0 in Q3 2025, compared to $0.0 in Q1 2025 and $0.0 in Q4 2024.